Insider Trading disclosures for Rallybio Corp

The latest disclosure was made by Steven Ryder in Rallybio Corp where a trade of 180,000 Option (Right to Buy) done was reported to US exchanges on Feb. 14, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Steven Ryder	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Feb 2025	180,000	180,000	-		-	Option (Right to Buy)
Stephen Uden	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Feb 2025	453,700	453,700	-		-	Option (Right to Buy)
Jonathan I. Lieber	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Feb 2025	180,000	180,000	-		-	Option (Right to Buy)
Hui Liu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	67,857	67,857	-		-	Option (Right to Buy)
Robert Hopfner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	73,571	73,571	-		-	Option (Right to Buy)
Ronald M. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	73,571	73,571	-		-	Option (Right to Buy)
Martin W. Mackay	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	92,857	92,857	-		-	Option (Right to Buy)
Helen M. Boudreau	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2024	16,500	16,500	-		-	Option (Right to Buy)
Ronald M. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2024	16,500	16,500	-		-	Option (Right to Buy)
Robert Hopfner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2024	16,500	16,500	-		-	Option (Right to Buy)
Christine A. Nash	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2024	16,500	16,500	-		-	Option (Right to Buy)
Paula Soteropoulos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2024	16,500	16,500	-		-	Option (Right to Buy)
Hui Liu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2024	16,500	16,500	-		-	Option (Right to Buy)
Kush M. Parmar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2024	16,500	16,500	-		-	Option (Right to Buy)
Wendy K. Chung	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2024	16,500	16,500	-		-	Option (Right to Buy)
Steven Ryder	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2024	120,000	120,000	-		-	Option (Right to Buy)
Mackay W. Martin	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2024	216,000	216,000	-		-	Option (Right to Buy)
Uden Stephen	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2024	216,000	216,000	-		-	Option (Right to Buy)
I. Lieber Jonathan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2024	120,000	120,000	-		-	Option (Right to Buy)
Ronald Hunt M.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	29,096	29,096	-		-	Option (Right to Buy)
M. Kush Parmar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2024	27,118	27,118	-		-	Option (Right to Buy)
Jonathan I. Lieber	See Remarks	Purchase of securities on an exchange or from another person at price $ 5.21 per share.	14 Mar 2023	5,000	5,000	-	5.2	26,050	Common Stock
Kush M. Parmar	Director	Sale of securities on an exchange or to another person at price $ 8.20 per share.	07 Mar 2023	100,000	2,378,969	-	8.2	820,000	Common Stock
Martin W. Mackay	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2023	214,000	214,000	-		-	Option (Right to Buy)
Stephen Uden	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2023	214,000	214,000	-		-	Option (Right to Buy)
Steven Ryder	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2023	119,000	119,000	-		-	Option (Right to Buy)
Jonathan I. Lieber	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	240,000	240,000	-		-	Option (Right to Buy)
Kush M. Parmar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	10,344	10,344	-		-	Option (Right to Buy)
Hui Liu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	10,237	10,237	-		-	Option (Right to Buy)
Ronald M. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	11,099	11,099	-		-	Option (Right to Buy)
Wendy K. Chung	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Jan 2023	9,482	9,482	-		-	Option (Right to Buy)
Wendy K. Chung	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Aug 2022	26,880	26,880	-		-	Option (Right to Buy)
Kush M. Parmar	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 12.50 per share.	03 Jun 2022	99,671	2,478,969	-	12.5	1,245,888	Common Stock
Kush M. Parmar	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 12.50 per share.	03 Jun 2022	50,329	1,251,755	-	12.5	629,113	Common Stock
Kush M. Parmar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2022	13,440	13,440	-		-	Option (Right to Buy)
Hui Liu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2022	2,240	2,240	-		-	Option (Right to Buy)
Helen M. Boudreau	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2022	13,440	13,440	-		-	Option (Right to Buy)
Paula Soteropoulos	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2022	13,440	13,440	-		-	Option (Right to Buy)
Christine A. Nash	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2022	2,240	2,240	-		-	Option (Right to Buy)
Robert Hopfner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2022	13,440	13,440	-		-	Option (Right to Buy)
Ronald M. Hunt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2022	13,440	13,440	-		-	Option (Right to Buy)
Kush M. Parmar	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 13.00 per share.	23 May 2022	33,553	1,302,084	-	13	436,189	Common Stock
Kush M. Parmar	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 13.00 per share.	23 May 2022	66,447	2,578,640	-	13	863,811	Common Stock
Christine A. Nash	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Apr 2022	26,880	26,880	-		-	Option (Right to Buy)
Hui Liu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Apr 2022	26,880	26,880	-		-	Option (Right to Buy)
Jeffrey M. Fryer	See Remarks	Purchase of securities on an exchange or from another person at price $ 8.04 per share.	21 Mar 2022	3,000	47,048	-	8.0	24,120	Common Stock
Kush M. Parmar	Director	Sale of securities on an exchange or to another person at price $ 13.05 per share.	08 Feb 2022	139,539	2,645,087	-	13.1	1,820,984	Common Stock
Kush M. Parmar	Director	Sale of securities on an exchange or to another person at price $ 13.05 per share.	08 Feb 2022	70,461	1,335,637	-	13.0	919,516	Common Stock
Steven Ryder	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2022	62,000	62,000	-		-	Option (Right to Buy)
Jeffrey M. Fryer	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2022	62,000	62,000	-		-	Option (Right to Buy)

Showing 1 to 50 of 82 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low today

High volume+loss today

Insider Trading disclosures for Rallybio Corp

The latest disclosure was made by Steven Ryder in Rallybio Corp where a trade of 180,000 Option (Right to Buy) done was reported to US exchanges on Feb. 14, 2025.

Screeners based on Insider Trading and SAST parameters